Hepatitis Monthly

Published by: Kowsar

Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes

Fahime Bahri 1 , Ali Kargar Kheirabad 2 , Iman Ghasemzadeh 3 , Saeed Shoja 3 and Hamed Gouklani 4 , *
Authors Information
1 Department of Microbiology, Jahrom Branch, Islamic Azad University, Jahrom, IR Iran
2 Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
3 Infectious and Tropical Disease Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran
4 Molecular Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran
Article information
  • Hepatitis Monthly: January 2016, 16 (1); e32971
  • Published Online: January 23, 2016
  • Article Type: Research Article
  • Received: September 6, 2015
  • Accepted: December 19, 2015
  • DOI: 10.5812/hepatmon.32971

To Cite: Bahri F, Kargar Kheirabad A, Ghasemzadeh I, Shoja S, Gouklani H. et al. Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes, Hepat Mon. 2016 ;16(1):e32971. doi: 10.5812/hepatmon.32971.

Abstract
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Dodd RY. Current viral risks of blood and blood products. Ann Med. 2000; 32(7): 469-74[PubMed]
  • 2. Chow KM, Szeto CC, Wu AK, Leung CB, Kwan BC, Li PK. Continuous ambulatory peritoneal dialysis in patients with hepatitis B liver disease. Perit Dial Int. 2006; 26(2): 213-7[PubMed]
  • 3. Mayhall CG. Hospital epidemiology and infection control. 2012;
  • 4. Pérez ER. Catheter-Related Bloodstream Infections in Critical Care. 2012;
  • 5. Mashragi F, Bernstein RS, Al-Mazroa M, Al-Tawfiq JA, Filemban S, Assiri A, et al. HIV transmission at a Saudi Arabia hemodialysis unit. Clin Infect Dis. 2014; 59(6): 897-902[DOI][PubMed]
  • 6. Su Y, Yan R, Duan Z, Norris JL, Wang L, Jiang Y, et al. Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China. J Med Virol. 2013; 85(3): 425-32[DOI][PubMed]
  • 7. Mohammed AA, Enan KA, Khair OM, Hussien MO, El Hussein ARM, Elkhidir IM. Prevalence of occult hepatitis B virus (HBV) infections in haemodialysis patients in Khartoum State, Sudan from 2012 to 2014. J Med Lab Diagn. 2015; 6(4): 22-6
  • 8. Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012; 12(4): 253-8[DOI][PubMed]
  • 9. Palanisamy S, Patil SB, Baskaran K, Narayana HS. Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit. BMC Infect Dis. 2012; 12
  • 10. Mittal G, Gupta P, Thakuria B, Mukhiya GK, Mittal M. Profile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in uttarakhand. J Clin Exp Hepatol. 2013; 3(1): 24-8[DOI][PubMed]
  • 11. Gomes-Gouvea MS, Pereira Soares Mdo C, Guedes de Carvalho Mello IM, Brito EM, Pereira Moia Lde J, Bensabath G, et al. Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin. Acta Trop. 2008; 106(3): 149-55[DOI][PubMed]
  • 12. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005; 23(19): 2409-23[DOI][PubMed]
  • 13. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006; 20(16)-23[DOI][PubMed]
  • 14. Arien KK, Abraha A, Quinones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol. 2005; 79(14): 8979-90[DOI][PubMed]
  • 15. Asim M, Singla R, Gupta RK, Kar P. Clinical & molecular characterization of human TT virus in different liver diseases. Indian J Med Res. 2010; 131: 545-54[PubMed]
  • 16. Lindh M, Gonzalez JE, Norkrans G, Horal P. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods. 1998; 72(2): 163-74[PubMed]
  • 17. Cotrina M, Buti M, Jardi R, Quer J, Rodriguez F, Pascual C, et al. Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia). J Hepatol. 1998; 28(6): 971-7[PubMed]
  • 18. Steegen K, Demecheleer E, De Cabooter N, Nges D, Temmerman M, Ndumbe P, et al. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance. J Virol Methods. 2006; 133(2): 137-45[DOI][PubMed]
  • 19. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012; 12(5): 339-43[DOI][PubMed]
  • 20. Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, Foroughi M, et al. Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 21. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008; 12(3): 378-82[DOI][PubMed]
  • 22. Mostaghni AA, Soltanian A, Mokhtari E, Japoni S, Mehrabani D. Seroprevalence of hepatitis B virus among hemodialysis patients in Bushehr province, southern Iran: HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011; 11(3): 200-2[PubMed]
  • 23. Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant. 2009; 24(5): 1598-603[DOI][PubMed]
  • 24. Otedo AE, Mc'Ligeyo SO, Okoth FA, Kayima JK. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J. 2003; 93(5): 380-4[PubMed]
  • 25. Kew MC. Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans. Hepat Mon. 2012; 12(10 hcc)[DOI][PubMed]
  • 26. Gasim GI, Hamdan HZ, Hamdan SZ, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. J Med Virol. 2012; 84(1): 52-5[DOI][PubMed]
  • 27. Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, et al. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Mem Inst Oswaldo Cruz. 2003; 98(5): 599-603[PubMed]
  • 28. Ferreira RC, Teles SA, Dias MA, Tavares VR, Silva SA, Gomes SA, et al. Hepatitis B virus infection profile in hemodialysis patients in Central Brazil: prevalence, risk factors, and genotypes. Mem Inst Oswaldo Cruz. 2006; 101(6): 689-92[PubMed]
  • 29. Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Dis. 2012; 12: 265[DOI][PubMed]
  • 30. Alashek WA, McIntyre CW, Taal MW. Determinants of survival in patients receiving dialysis in Libya. Hemodial Int. 2013; 17(2): 249-55[DOI][PubMed]
  • 31. Neisi N, Makvandi M, Samarbaf-Zadeh AR. A study on genotypes of hepatitis B virus among hemodialysis patients in Khuzestan province. Jundishapur J Microbiol. 2011; 4(2): 65-70
  • 32. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Mahboudi F, Sabahi F, Adeli A, Noorinayer B, et al. Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J Med Virol. 2005; 75(2): 227-34[DOI][PubMed]
  • 33. Taghavi SA, Tabibi M, Eshraghian A, Keyvani H, Eshraghian H. Prevalence and clinical significance of hepatitis B Basal core promoter and precore gene mutations in southern Iranian patients. Hepat Mon. 2010; 10(4): 294-7[PubMed]
  • 34. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology. 1995; 38(1-2): 24-34[PubMed]
  • 35. Pivert A, Servant-Delmas A, Lunel-Fabiani F, Le Guillou-Guillemette H, Laperche S, Ducancelle A. Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus. J Med Virol. 2015; 87(3): 529-35[DOI][PubMed]
  • 36. Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, et al. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol. 1993; 74 ( Pt 7): 1341-8[DOI][PubMed]
  • 37. Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol. 2002; 83: 1267-80[DOI][PubMed]
  • 38. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003; 63(6): 2222-9[DOI][PubMed]
  • 39. Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001; 91(1): 31-7[PubMed]
  • 40. El-Ottol AEKY, Elmanama AA, Ayesh BM. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine. Virol J. 2010; 7: 210[DOI][PubMed]
  • 41. Vladutiu DS, Cosa A, Neamtu A, State D, Braila M, Gherman M, et al. Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? J Viral Hepat. 2000; 7(4): 313-9[PubMed]
  • 42. Mahdavimazdeh M, Hosseini-Moghaddam SM, Alavian SM, Yahyazadeh H. Hepatitis B Infection in hemodialysis patients in Tehran province, Iran. Hepat Mon. 2009; 9(3): 206-10
  • 43. Sartor C, Brunet P, Simon S, Tamalet C, Berland Y, Drancourt M. Transmission of hepatitis C virus between hemodialysis patients sharing the same machine. Infect Control Hosp Epidemiol. 2004; 25(7): 609-11[DOI][PubMed]
  • 44. Hashemi B, Mahdavi-Mazdeh M, Abbasi M, Hosseini-Moghaddam SM, Zinat NH, Ahmadi F. Efficacy of HBV vaccination in various stages of chronic kidney disease: is earlier better? Hepat Mon. 2011; 11(10): 816-20[DOI][PubMed]
  • 45. Jadoul M, Goubau P. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clin Nephrol. 2002; 58(4): 301-4[PubMed]
  • 46. Hussain M, Chu CJ, Sablon E, Lok AS. Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants. J Clin Microbiol. 2003; 41(8): 3699-705[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader